Mutual of America Capital Management’s Astera Labs ALAB Stock Holding History

Mutual of America Capital Management’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$753K	Buy	+1,559	New	+$414K	0.01%	1050

Other funds holding ALAB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Mutual of America Capital Management's ALAB Position: Q2 2026 in Review

Mutual of America Capital Management opened a new position in Astera Labs (ALAB) in Q2 2026: 1,559 shares worth $753K. The stake represents 0.01% of the portfolio and ranks #1050 among its holdings.

732 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

Mutual of America Capital Management held 1,559 shares of Astera Labs worth $753K as of Q2 2026.
Astera Labs was a new Mutual of America Capital Management position in Q2 2026.
Astera Labs made up 0.01% of Mutual of America Capital Management's portfolio in Q2 2026, its #1050 holding.
732 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Mutual of America Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.